The first report of quality of life in patients with NLPHL from our ongoing NLPHLPRO multicenter trial (NCT06098430), presented by Dr. Jones at #ISCAYAHL.

Long-term survivors (most who received chemo) have low symptom burden and high global QOL & functioning. #lymsm cc @cuhematology.bsky.social